Well-differentiated and dedifferentiated liposarcomas

Virchows Archiv

Volumn 456, Issue 2, 2010, Pages 167-179

  Coindre, Jean Michel ^a,b   Pédeutour, Florence ^c   Aurias, Alain ^d  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CENTRE DE BIOCHIMIE   (France)

^d INSTITUT CURIE   (France)

Author keywords

CDK4; Dedifferentiated liposarcoma; MDM2; Well differentiated liposarcoma

Indexed keywords

DEHYDRODIDEMNIN B; FLAVOPIRIDOL; PROTEIN MDM2; THIOREDOXIN; CYCLIN DEPENDENT KINASE 4; MDM2 PROTEIN, HUMAN;

ADIPOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER EPIDEMIOLOGY; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 12Q; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG EFFICACY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOSARCOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; REVIEW; TUMOR DIFFERENTIATION; XENOGRAFT; GENE AMPLIFICATION; GENETICS; KARYOTYPING; PATHOLOGY;

CYCLIN-DEPENDENT KINASE 4; GENE AMPLIFICATION; HUMANS; KARYOTYPING; LIPOSARCOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MDM2;

EID: 77950346817     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0815-x     Document Type: Review

References (46)

1. Fletcher CDM, Unni KK, Mertens F (2002) Pathology and genetics. Tumours of soft tissue and bone. IARC, Lyon
2. Idbaih A, Coindre JM, Derré J et al (2005) Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 85:176-181
3. Willems SM, Debiec-Rychter M, Szuhai K et al (2006) Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 19:407-416
4. Rubin BP, Fletcher CDM (1997) The cytologenetics of lipomatous tumours. Histopathology 30:507-511
5. Pedeutour F, Marie G, Sirvent N (2004) De la cytogénétique à la cytogénomique des tumeurs adipocytaires. 2. Tumeurs adipocytaires malignes. Bull Cancer 91:317-323
6. Sandberg AA (2004) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma. Cancer Genet Cytogenet 155:1-24
7. Pedeutour F, Suijkerbuijk RF, Forus A et al (1994) Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcomas. Genes Chromosomes Cancer 10:85-94
8. Italiano A, Blanchini L, Keslair F et al (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinctive inconsistent amplicon. Int J Cancer 122:2233-2241
9. Sirvent N, Forus A, Lescaut W et al (2000) Characterization of centromere alterations in liposarcomas. Genes Chromosomes Cancer 29:117-129
10. Pedeutour F, Forus A, Coindre JM et al (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30-41
11. Italiano A, Maire G, Sirvent N et al (2009) Variability of origin for the neocentromeric sequences in analphoid supernumerary marker chromosomes of well-differentiated liposarcomas. Cancer Lett 273:323-330
12. Sirvent N, Coindre JM, Marie G et al (2007) Detection of MDM2- CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol 31:1476-1489
13. Bui Nguyen Binh M, Sastre-Garau X, Guillou L et al (2005) MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes. A comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 29:1340-1347
14. Chibon F, Mariani O, Derré J et al (2002) A subgroup of malignant fibrous histiocytomas in associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 139:24-29
15. Mariani O, Brennetot C, Coindre JM et al (2007) JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas. Cancer Cell 11:361-374
16. Chibon F, Mariani O, Derré J et al (2004) ASKI (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-15 and 6q23 amplifications. Genes Chromosomes Cancer 40:32-37
17. Momand J, Wu HH, Dasgupta G (2000) MDM2-master regulator of the p53 tumor suppressor protein. Gene 242:15-29
18. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602:73-87
19. Castriota G, Thompson GM, Lin Y et al (2007) Peroxisome proliferator-activited receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein. Cell Biol Int 31:586-591
20. Singer S, Socci ND, Ambrosini G et al (2007) Gene expression profiling of liposarcoma identifies distinct biological types/ subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67:6626-6636
21. Müller CR, Paulsen EB, Noordhuis P et al (2007) Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A. Int J Cancer 121:199-205
22. Shapiro GI (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J Clin Oncol 24:1770-1783
23. Cuadrado A, Gnozalez L, Suarez Y et al (2004) JNK activation is critical for Aplidin-induced apoptosis. Oncogene 23:4673-4680
24. Dei Tos AP, Pedeutour F (2002) Atypical lipomatous tumour/well differentiated liposarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and Genetics. Tumours of soft tissue and bone. IARC, Lyon, pp 35-37
25. Pilotti S, Della Torre G, Mezzelani A et al (2000) The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma. Br J Cancer 82:1271-1275
26. Dalal KM, Kattan MW, Antonescu CR et al (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244:381-391
27. Weiss SW, Goldblum JR (2008) Liposarcoma. In: Weiss SW, Goldblum JR (eds) Enzinger and Weiss's soft tissue tumors. Mosby, St Louis, pp 477-516
28. Kraus MD, Guillou L, Fletcher CD (1997) Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. Am J Surg Pathol 1:37-50
29. Weaver J, Downs-Kelly E, Goldblum JR et al (2008) Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 21:943-949
30. Evans HL, Soule EH, Winkelman RK (1979) Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma. Cancer 43:574
31. Azumi N, Curtis J, Kempson RL et al (1987) Atypical and malignant neoplasms showing lipomatous differentiation: a study of 111 cases. Am J Surg Pathol 11:161
32. Weiss SW, Rao VK (1992) Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum and miscellaneous sites: a follow-up study of 92 cases with analysis of the incidence of "dedifferentiated". Am J Surg Pathol 16:1051
33. Evans HL (1979) Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol 3:507-523
34. Henricks WH, Chu YC, Goldblum JR et al (1997) Dedifferentiated liposarcoma. A clinicopathologic analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 21:271-281
35. McCormick D, Mentzel T, Beham A et al (1994) Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol 18:1213-1223
36. Dalal KM, Kattan MW, Antonescu CR et al (2006) Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 244:381-391
37. Dei Tos AP, Pedeutour F (2002) Dedifferentiated liposarcoma. In: Fletcher CDM, Unni KK, Mertens F (eds) Pathology and genetics-tumours of soft tissue and bone. IARC, Lyon, pp 38-39
38. Coindre JM, Mariani O, Chibon F et al (2003) Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma. Mod Pathol 16:256-262
39. Coindre JM, Hostein I,Maire G et al (2004) Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203:822-830
40. Tallini G, Erlandson RA, Brennan MF et al (1993) Divergent myosarcomatous differentiation in retroperitoneal liposarcoma. Am J Surg Pathol 17:546-556
41. Evans HL, Khurana KK, Kemp BL et al (1994) Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma. Am J Surg Pathol 18:1150-1157
42. Bui Nguyen Binh M, Guillou L, Hostein I et al (2007) Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk. A study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol 31:1557-1566
43. Fanburg-Smith JC, Miettinen M (1998) Liposarcoma with meningothelial-like whorls: a study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma. Histopathological 33:414-424
44. Nascimento AG, Kurtin PJ, Guillou L et al (1998) Dedifferentiated liposarcoma: a report of nine cases with a peculiar neurolike whorling pattern associatedwithmetaplastic bone formation.Am J Surg Pathol 22:945-955
45. Willems SW, Szuhai K, Hartgrink H et al (2007) CT-guided, COBRA-FISH-assisted diagnosis of well-differentiated liposarcoma (inflammatory subtype) of the retroperitoneum. Histopathology 51:422-426 (Pubitemid 47301620)
46. Mussi C, Collini P, Miceli R et al (2008) The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer 113:1657-1665